Risk of tuberculosis in patients treated with anti-tumor necrosis factor therapy: a nationwide study in South Korea, a country with an intermediate tuberculosis burden-Reference-Cited by-同舟云学术

Risk of tuberculosis in patients treated with anti-tumor necrosis factor therapy: a nationwide study in South Korea, a country with an intermediate tuberculosis burden

Published:2015-01-03 Issue:3 Volume:18 Page:323-330
ISSN:1756-1841
Container-title:International Journal of Rheumatic Diseases
language:en
Short-container-title:Int J Rheum Dis

Author:

Jung Seung Min¹,Ju Ji Hyeon¹,Park Mi-Sun²,Kwok Seung-Ki¹,Park Kyung-Su¹,Kim Ho-Youn¹,Yim Hyeon Woo²,Park Sung-Hwan¹

Affiliation:

1. Division of Rheumatology; Department of Internal Medicine; The Catholic University of Korea; Seoul St. Mary's Hospital; Seoul South Korea

2. Clinical Research Supporting Center; College of Medicine; The Catholic University of Korea; Seoul South Korea

Publisher

Wiley

Subject

Rheumatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1756-185X.12530/fullpdf

Reference27 articles.

1. Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists;Curtis;Arthritis Rheum,2007

2. Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists;Askling;Ann Rheum Dis,2007

3. Observational studies of infections in rheumatoid arthritis: a metaanalysis of tumor necrosis factor antagonists;Bernatsky;J Rheumatol,2010

4. Role of tumour necrosis factor (TNF) in host defence against tuberculosis: implications for immunotherapies targeting TNF;Ehlers;Ann Rheum Dis,2003

5. Tumour necrosis factor antagonists: structure, function, and tuberculosis risks;Wallis;Lancet Infect Dis,2008

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biologics Versus JAK Inhibitors. Part II: Risk of Infections. A Narrative Review;Dermatology and Therapy;2024-07-16

2. Drug Persistence and Incidence of Active Tuberculosis of Tumor Necrosis Factor Alpha Inhibitors Versus Tocilizumab as the First-Line Biological Treatment in Patients with Rheumatoid Arthritis: A Nationwide Population-Based Retrospective Cohort Analysis;Rheumatology and Therapy;2024-05-20

3. Mycobacterium tuberculosis sepsis with multiple intermuscular abscesses and respiratory failure as the main manifestations: a case report;BMC Infectious Diseases;2024-03-21

4. Regional risk of tuberculosis and viral hepatitis with tumor necrosis factor-alpha inhibitor treatment: A systematic review;Frontiers in Pharmacology;2023-01-20

5. IBD barriers across the continents – East Asia;Therapeutic Advances in Gastroenterology;2023-01